A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies

Ernest Turro, Daniel Greene, Anouck Wijgaerts, Chantal Thys, Claire Lentaigne, Tadbir K Bariana, Sarah K Westbury, Anne M Kelly, Dominik Selleslag, Jonathan C Stephens, Sofia Papadia, Ilenia Simeoni, Christopher J Penkett, Sofie Ashford, Antony Attwood, Steve Austin, Tamam Bakchoul, Peter Collins, Sri V V Deevi, Rémi FavierMyrto Kostadima, Michele P Lambert, Mary Mathias, Carolyn M Millar, Kathelijne Peerlinck, David J Perry, Sol Schulman, Deborah Whitehorn, Christine Wittevrongel, BRIDGE-BPD Consortium, Marc De Maeyer, Augusto Rendon, Keith Gomez, Wendy N Erber, Andrew D Mumford, Paquita Nurden, Kathleen Stirrups, John R Bradley, F Lucy Raymond, Michael A Laffan, Chris Van Geet, Sylvia Richardson, Kathleen Freson, Willem H Ouwehand

Research output: Contribution to journalArticle (Academic Journal)peer-review

91 Citations (Scopus)
412 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science